DocCheck AG
XETRA:AJ91
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.15
9.75
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one AJ91 stock under the Base Case scenario is 17.45 EUR. Compared to the current market price of 8.3 EUR, DocCheck AG is Undervalued by 52%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
DocCheck AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for AJ91 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
DocCheck AG
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
DocCheck AG
Balance Sheet Decomposition
DocCheck AG
Current Assets | 34.9m |
Cash & Short-Term Investments | 20.6m |
Receivables | 11.2m |
Other Current Assets | 3.2m |
Non-Current Assets | 20.8m |
Long-Term Investments | 5.8m |
PP&E | 14.8m |
Intangibles | 106.8k |
Other Non-Current Assets | 83.7k |
Current Liabilities | 13.6m |
Accounts Payable | 1.9m |
Other Current Liabilities | 11.7m |
Non-Current Liabilities | 5.5m |
Other Non-Current Liabilities | 5.5m |
Earnings Waterfall
DocCheck AG
Revenue
|
51.6m
EUR
|
Cost of Revenue
|
-10.3m
EUR
|
Gross Profit
|
41.3m
EUR
|
Operating Expenses
|
-37.5m
EUR
|
Operating Income
|
3.8m
EUR
|
Other Expenses
|
-1.4m
EUR
|
Net Income
|
2.4m
EUR
|
Free Cash Flow Analysis
DocCheck AG
EUR | |
Free Cash Flow | EUR |
AJ91 Profitability Score
Profitability Due Diligence
DocCheck AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
DocCheck AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
AJ91 Solvency Score
Solvency Due Diligence
DocCheck AG's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
DocCheck AG's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AJ91 Price Targets Summary
DocCheck AG
Dividends
Current shareholder yield for AJ91 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
AJ91 Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
DocCheck AG operates as a holding company, which specializes in healthcare growth market. The company is headquartered in Cologne, Nordrhein-Westfalen and currently employs 372 full-time employees. The company went IPO on 2011-11-04. The company operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies.
Contact
IPO
Employees
Officers
The intrinsic value of one AJ91 stock under the Base Case scenario is 17.45 EUR.
Compared to the current market price of 8.3 EUR, DocCheck AG is Undervalued by 52%.